198 related articles for article (PubMed ID: 32235485)
1. Genetic and Clinical Heterogeneity in Thirteen New Cases with Aceruloplasminemia. Atypical Anemia as a Clue for an Early Diagnosis.
Vila Cuenca M; Marchi G; Barqué A; Esteban-Jurado C; Marchetto A; Giorgetti A; Chelban V; Houlden H; Wood NW; Piubelli C; Dorigatti Borges M; Martins de Albuquerque D; Yotsumoto Fertrin K; Jové-Buxeda E; Sanchez-Delgado J; Baena-Díez N; Burnyte B; Utkus A; Busti F; Kaubrys G; Suku E; Kowalczyk K; Karaszewski B; Porter JB; Pollard S; Eleftheriou P; Bignell P; Girelli D; Sanchez M
Int J Mol Sci; 2020 Mar; 21(7):. PubMed ID: 32235485
[TBL] [Abstract][Full Text] [Related]
2. Aceruloplasminemia in a Turkish adolescent with a novel mutation of ceruloplasmin gene: the first diagnosed case from Turkey.
Meral Gunes A; Sezgin Evim M; Baytan B; Iwata A; Hida A; Avci R
J Pediatr Hematol Oncol; 2014 Oct; 36(7):e423-5. PubMed ID: 25247888
[TBL] [Abstract][Full Text] [Related]
3. Criteria for early identification of aceruloplasminemia.
Ogimoto M; Anzai K; Takenoshita H; Kogawa K; Akehi Y; Yoshida R; Nakano M; Yoshida K; Ono J
Intern Med; 2011; 50(13):1415-8. PubMed ID: 21720062
[TBL] [Abstract][Full Text] [Related]
4. Clinical relevance of heterozygosis for aceruloplasminemia.
Borges MD; de Albuquerque DM; Lanaro C; Costa FF; Fertrin KY
Am J Med Genet B Neuropsychiatr Genet; 2019 Jun; 180(4):266-271. PubMed ID: 30901137
[TBL] [Abstract][Full Text] [Related]
5. [Aceruloplasminemia, a rare condition not to be overlooked].
Lobbes H; Reynaud Q; Mainbourg S; Lega JC; Durieu I; Durupt S
Rev Med Interne; 2020 Nov; 41(11):769-775. PubMed ID: 32682623
[TBL] [Abstract][Full Text] [Related]
6. Aceruloplasminemia.
Kono S
Curr Drug Targets; 2012 Aug; 13(9):1190-9. PubMed ID: 22515740
[TBL] [Abstract][Full Text] [Related]
7. Phenotypic heterogeneity in seven Italian cases of aceruloplasminemia.
Pelucchi S; Mariani R; Ravasi G; Pelloni I; Marano M; Tremolizzo L; Alessio M; Piperno A
Parkinsonism Relat Disord; 2018 Jun; 51():36-42. PubMed ID: 29503155
[TBL] [Abstract][Full Text] [Related]
8. Aceruloplasminemia presents as Type 1 diabetes in non-obese adults: a detailed case series.
Vroegindeweij LH; van der Beek EH; Boon AJ; Hoogendoorn M; Kievit JA; Wilson JH; Langendonk JG
Diabet Med; 2015 Aug; 32(8):993-1000. PubMed ID: 25661792
[TBL] [Abstract][Full Text] [Related]
9. Aceruloplasminemia: an update.
Kono S
Int Rev Neurobiol; 2013; 110():125-51. PubMed ID: 24209437
[TBL] [Abstract][Full Text] [Related]
10. Ceruloplasmin deficiency does not induce macrophagic iron overload: lessons from a new rat model of hereditary aceruloplasminemia.
Kenawi M; Rouger E; Island ML; Leroyer P; Robin F; Rémy S; Tesson L; Anegon I; Nay K; Derbré F; Brissot P; Ropert M; Cavey T; Loréal O
FASEB J; 2019 Dec; 33(12):13492-13502. PubMed ID: 31560858
[TBL] [Abstract][Full Text] [Related]
11. New mutation of the ceruloplasmin gene in the case of a neurologically asymptomatic patient with microcytic anaemia, obesity and supposed Wilson's disease.
Ondrejkovičová M; Dražilová S; Drakulová M; Siles JL; Zemjarová Mezenská R; Jungová P; Fabián M; Rychlý B; Žigrai M
BMC Gastroenterol; 2020 Apr; 20(1):95. PubMed ID: 32264837
[TBL] [Abstract][Full Text] [Related]
12. Aceruloplasminemia and putaminal cavitation.
Riboldi GM; Anstett K; Jain R; Lau H; Swope D
Parkinsonism Relat Disord; 2018 Jun; 51():121-123. PubMed ID: 29534945
[No Abstract] [Full Text] [Related]
13. Novel ceruloplasmin mutation causing aceruloplasminemia with hepatic iron overload and diabetes without neurological symptoms.
Rusticeanu M; Zimmer V; Schleithoff L; Wonney K; Viera J; Zimmer A; Hübschen U; Bohle RM; Grünhage F; Lammert F
Clin Genet; 2014 Mar; 85(3):300-1. PubMed ID: 23557349
[No Abstract] [Full Text] [Related]
14. Molecular and pathological basis of aceruloplasminemia.
Kono S; Miyajima H
Biol Res; 2006; 39(1):15-23. PubMed ID: 16629161
[TBL] [Abstract][Full Text] [Related]
15. A novel ceruloplasmin mutation identified in a Chinese patient and clinical spectrum of aceruloplasminemia patients.
Xu WQ; Ni W; Wang RM; Dong Y; Wu ZY
Metab Brain Dis; 2021 Dec; 36(8):2273-2281. PubMed ID: 34347207
[TBL] [Abstract][Full Text] [Related]
16. Aceruloplasminemia presenting with microcytic anemia in a Turkish boy due to a novel pathogenic variant.
Gok V; Ozcan A; Ozer S; Karaman F; Aykutlu E; Yilmaz E; Karakukcu M; Bisgin A; Unal E
Pediatr Hematol Oncol; 2023; 40(7):673-681. PubMed ID: 36308763
[TBL] [Abstract][Full Text] [Related]
17. Hepatic but not brain iron is rapidly chelated by deferasirox in aceruloplasminemia due to a novel gene mutation.
Finkenstedt A; Wolf E; Höfner E; Gasser BI; Bösch S; Bakry R; Creus M; Kremser C; Schocke M; Theurl M; Moser P; Schranz M; Bonn G; Poewe W; Vogel W; Janecke AR; Zoller H
J Hepatol; 2010 Dec; 53(6):1101-7. PubMed ID: 20801540
[TBL] [Abstract][Full Text] [Related]
18. Aceruloplasminemia: an inherited neurodegenerative disease with impairment of iron homeostasis.
Xu X; Pin S; Gathinji M; Fuchs R; Harris ZL
Ann N Y Acad Sci; 2004 Mar; 1012():299-305. PubMed ID: 15105274
[TBL] [Abstract][Full Text] [Related]
19. Effectiveness of oral iron chelator treatment with deferasirox in an aceruloplasminemia patient with a novel ceruloplasmin gene mutation.
Suzuki Y; Yoshida K; Aburakawa Y; Kuroda K; Kimura T; Terada T; Kono S; Miyajima H; Yahara O
Intern Med; 2013; 52(13):1527-30. PubMed ID: 23812204
[TBL] [Abstract][Full Text] [Related]
20. Aceruloplasminemia: an inherited neurodegenerative disease with impairment of iron homeostasis.
Harris ZL; Klomp LW; Gitlin JD
Am J Clin Nutr; 1998 May; 67(5 Suppl):972S-977S. PubMed ID: 9587138
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]